Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
ConditionColorectal Carcinoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorMayo Clinic
About this trial
This clinical trial studies disparities involving colorectal cancer prevention and screening in Black and underserved communities in the Phoenix metropolitan area. The Black community is disproportionately impacted by colorectal cancer, with the highest rate of any racial/ethnic group in the United States. There are complex reasons behind these disparities, largely related to socioeconomic factors and healthcare access. Providing access to free, home-based fecal immunochemical testing (FIT), colorectal screening education, and appropriate follow-up to predominantly Black community-based organizations and underserved communities may help to close this gap.
Eligibility criteria
Qualifiers
Age 45 years of age or older
No prior history of colorectal cancer or colon polyps
No first-degree family history of colorectal cancer who were diagnosed under age 60
No current gastrointestinal (GI) or rectal symptoms (such as rectal bleeding)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Educational Intervention
- Fecal Immunochemical Test
- Patient Navigation
- Questionnaire Administration
Treatment groups
450 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov